133 related articles for article (PubMed ID: 25170553)
1. Pain in adolescent girls receiving human papillomavirus vaccine with concomitantly administered vaccines.
Walter EB; Kemper AR; Dolor RJ; Dunne EF
Pediatr Infect Dis J; 2015 Feb; 34(2):200-2. PubMed ID: 25170553
[TBL] [Abstract][Full Text] [Related]
2. Safety of quadrivalent human papillomavirus vaccine administered routinely to females.
Klein NP; Hansen J; Chao C; Velicer C; Emery M; Slezak J; Lewis N; Deosaransingh K; Sy L; Ackerson B; Cheetham TC; Liaw KL; Takhar H; Jacobsen SJ
Arch Pediatr Adolesc Med; 2012 Dec; 166(12):1140-8. PubMed ID: 23027469
[TBL] [Abstract][Full Text] [Related]
3. Long-term study of a quadrivalent human papillomavirus vaccine.
Ferris D; Samakoses R; Block SL; Lazcano-Ponce E; Restrepo JA; Reisinger KS; Mehlsen J; Chatterjee A; Iversen OE; Sings HL; Shou Q; Sausser TA; Saah A
Pediatrics; 2014 Sep; 134(3):e657-65. PubMed ID: 25136050
[TBL] [Abstract][Full Text] [Related]
4. A case-control study of quadrivalent human papillomavirus vaccine-associated autoimmune adverse events.
Geier DA; Geier MR
Clin Rheumatol; 2015 Jul; 34(7):1225-31. PubMed ID: 25535199
[TBL] [Abstract][Full Text] [Related]
5. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):630-2. PubMed ID: 20508594
[TBL] [Abstract][Full Text] [Related]
6. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):626-9. PubMed ID: 20508593
[TBL] [Abstract][Full Text] [Related]
7. An open-label, randomized, multicenter study of the safety, tolerability, and immunogenicity of quadrivalent human papillomavirus (types 6/11/16/18) vaccine given concomitantly with diphtheria, tetanus, pertussis, and poliomyelitis vaccine in healthy adolescents 11 to 17 years of age.
Vesikari T; Van Damme P; Lindblad N; Pfletschinger U; Radley D; Ryan D; Vuocolo S; Haupt RM; Guris D
Pediatr Infect Dis J; 2010 Apr; 29(4):314-8. PubMed ID: 19952980
[TBL] [Abstract][Full Text] [Related]
8. Adverse events following immunization in Ontario's female school-based HPV program.
Harris T; Williams DM; Fediurek J; Scott T; Deeks SL
Vaccine; 2014 Feb; 32(9):1061-6. PubMed ID: 24440208
[TBL] [Abstract][Full Text] [Related]
9. An investigation of three injections techniques in reducing local injection pain with a human papillomavirus vaccine: a randomized trial.
Petousis-Harris H; Poole T; Stewart J; Turner N; Goodyear-Smith F; Coster G; Lennon D
Vaccine; 2013 Feb; 31(8):1157-62. PubMed ID: 23306361
[TBL] [Abstract][Full Text] [Related]
10. Uptake, coverage, and completion of quadrivalent human papillomavirus vaccine in the vaccine safety Datalink, July 2006-June 2011.
Schmidt MA; Gold R; Kurosky SK; Daley MF; Irving SA; Gee J; Naleway AL
J Adolesc Health; 2013 Nov; 53(5):637-41. PubMed ID: 24138765
[TBL] [Abstract][Full Text] [Related]
11. The influence of free quadrivalent human papillomavirus vaccine (HPV4) on the timely completion of the three dose series.
Harper DM; Verdenius I; Harris GD; Barnett AL; Rosemergey BE; Arey AM; Wall J; Malnar GJ
Prev Med; 2014 Apr; 61():20-5. PubMed ID: 24440159
[TBL] [Abstract][Full Text] [Related]
12. Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case-control assessment of the vaccine adverse event reporting system (VAERS) database.
Geier DA; Geier MR
Immunol Res; 2017 Feb; 65(1):46-54. PubMed ID: 27406735
[TBL] [Abstract][Full Text] [Related]
13. Factors predicting completion of the human papillomavirus vaccine series.
Gold R; Naleway A; Riedlinger K
J Adolesc Health; 2013 Apr; 52(4):427-32. PubMed ID: 23298984
[TBL] [Abstract][Full Text] [Related]
14. Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink.
Gee J; Naleway A; Shui I; Baggs J; Yin R; Li R; Kulldorff M; Lewis E; Fireman B; Daley MF; Klein NP; Weintraub ES
Vaccine; 2011 Oct; 29(46):8279-84. PubMed ID: 21907257
[TBL] [Abstract][Full Text] [Related]
15. Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(50):1705-8. PubMed ID: 22189893
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine coadministered with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine and/or meningococcal conjugate vaccine to healthy girls 11 to 18 years of age: results from a randomized open trial.
Wheeler CM; Harvey BM; Pichichero ME; Simon MW; Combs SP; Blatter MM; Marshall GS; Catteau G; Dobbelaere K; Descamps D; Dubin G; Schuind A
Pediatr Infect Dis J; 2011 Dec; 30(12):e225-34. PubMed ID: 21817954
[TBL] [Abstract][Full Text] [Related]
17. Antibody responses among adolescent females receiving the quadrivalent HPV vaccine series corresponding to standard or non-standard dosing intervals.
Russell K; Dunne EF; Kemper AR; Dolor RJ; Unger ER; Panicker G; Markowitz LE; Walter EB
Vaccine; 2015 Apr; 33(16):1953-8. PubMed ID: 25744229
[TBL] [Abstract][Full Text] [Related]
18. Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine.
Chao C; Klein NP; Velicer CM; Sy LS; Slezak JM; Takhar H; Ackerson B; Cheetham TC; Hansen J; Deosaransingh K; Emery M; Liaw KL; Jacobsen SJ
J Intern Med; 2012 Feb; 271(2):193-203. PubMed ID: 21973261
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial: immunogenicity and safety of coadministered human papillomavirus-16/18 AS04-adjuvanted vaccine and combined hepatitis A and B vaccine in girls.
Pedersen C; Breindahl M; Aggarwal N; Berglund J; Oroszlán G; Silfverdal SA; Szüts P; O'Mahony M; David MP; Dobbelaere K; Dubin G; Descamps D
J Adolesc Health; 2012 Jan; 50(1):38-46. PubMed ID: 22188832
[TBL] [Abstract][Full Text] [Related]
20. HPV vaccine and its recommendations, 2007.
Zimmerman RK
J Fam Pract; 2007 Feb; 56(2 Suppl Vaccines):S1-5, C1. PubMed ID: 17270106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
